Lupin Limited (LUPIN.BO) Stock Price, News & Chart

	LUPIN.BO	IPCALAB.NS	LAURUSLABS.NS	MOREPENLAB.NS	IOLCP.NS	000230.KS
Market cap	908.22B	494.62B	1.27T	53.21B	55.50B	65.20B
P/E (TTM)	21.1	37.8	94.7	28.3	27.3	—
Forward P/E	22.0	27.7	66.2	—	17.5	—
Price/book	4.6	6.1	20.9	3.9	2.9	—
Dividend yield	0.55%	0.30%	0.09%	0.20%	0.54%	1.79%
1-year change	+0.39%	+51.13%	+137.17%	+113.46%	+102.86%	−52.38%
Today	−1.36%	−1.14%	+0.96%	−4.17%	+2.89%	+0.89%

Market cap

908.22B

494.62B

1.27T

53.21B

55.50B

65.20B

P/E (TTM)

21.1

37.8

94.7

28.3

27.3

—

Forward P/E

22.0

27.7

66.2

—

17.5

—

Price/book

4.6

6.1

20.9

3.9

2.9

—

Dividend yield

0.55%

0.30%

0.09%

0.20%

0.54%

1.79%

1-year change

+0.39%

+51.13%

+137.17%

+113.46%

+102.86%

−52.38%

Today

−1.36%

−1.14%

+0.96%

−4.17%

+2.89%

+0.89%

Company	Mkt cap	Price	Today
Ipca Laboratories LimitedIPCALAB.NS · Drug Manufacturers - Specialty & Generic	494.62B	1,949.60	−1.14%
Laurus Labs LimitedLAURUSLABS.NS · Drug Manufacturers - Specialty & Generic	1.27T	2,346.00	+0.96%
Morepen Laboratories LimitedMOREPENLAB.NS · Drug Manufacturers - Specialty & Generic	53.21B	97.10	−4.17%
IOL Chemicals and Pharmaceuticals LimitedIOLCP.NS · Drug Manufacturers - Specialty & Generic	55.50B	189.08	+2.89%
Ildong Holdings Co., Ltd.000230.KS · Drug Manufacturers - Specialty & Generic	65.20B	5,650.00	+0.89%
Fredun Pharmaceuticals LimitedFREDUN.BO · Drug Manufacturers - Specialty & Generic	25.51B	1,493.45	−1.07%
RPG Life Sciences LimitedRPGLIFE.NS · Drug Manufacturers - Specialty & Generic	42.93B	2,595.70	−0.11%
Ind-Swift Laboratories LimitedINDSWFTLAB.NS · Drug Manufacturers - Specialty & Generic	31.52B	356.75	−3.72%

Company	Mkt cap	Price	Today
Sumitomo Pharma Co., Ltd.4506.T · Osaka, Japan	932.63B	2,079.00	+7.53%
Aurobindo Pharma LimitedAUROPHARMA.NS · Hyderabad, India	1.03T	1,785.00	+4.69%
HK inno.N Corporation195940.KQ · Cheongju-si, South Korea	1.04T	36,650.00	+7.01%
Mankind Pharma LimitedMANKIND.BO · New Delhi, India	1.04T	2,515.00	−0.72%
Cipla LimitedCIPLA.BO · Mumbai, India	1.13T	1,401.75	+0.12%
Dr. Reddy's Laboratories LimitedDRREDDY.NS · Hyderabad, India	1.14T	1,366.00	−0.58%
Daewoong Pharmaceutical Co., Ltd069620.KS · Seoul, South Korea	1.23T	106,700.00	+3.69%
Zydus Lifesciences LimitedZYDUSLIFE.NS · Ahmedabad, India	1.19T	1,193.00	+0.41%

Company	Mkt cap	Price	Today
JOHNSON & JOHNSON CDR (CAD HEDGJNJ.NE · Drug Manufacturers - General	915.54B	35.27	+4.32%
Bayer AktiengesellschaftBAYNN.MX · Drug Manufacturers - General	936.33B	953.08	0.00%
Pfizer Inc.PFIZ34.SA · Drug Manufacturers - General	953.24B	41.81	+1.38%
Danaher CorporationDHER34.SA · Diagnostics & Research	896.98B	45.57	−3.04%
Sumitomo Pharma Co., Ltd.4506.T · Drug Manufacturers - Specialty & Generic	932.63B	2,079.00	+7.53%
Asahi Intecc Co., Ltd.7747.T · Medical Instruments & Supplies	1.03T	3,890.00	+7.97%
Ingenia Therapeutics Inc.950260.KQ · Biotechnology	993.73B	20,100.00	+2.97%
Aurobindo Pharma LimitedAUROPHARMA.NS · Drug Manufacturers - Specialty & Generic	1.03T	1,785.00	+4.69%

Company	Mkt cap	Price	Today
ICICI Bank LimitedIBN.BA · Mumbai, India	188.59T	52,525.00	+4.48%
Reliance Industries LimitedRELIANCE.BO · Mumbai, India	17.78T	1,313.35	+0.08%
HDFC Bank LimitedHDFCBANK.NS · Mumbai, India	11.73T	760.00	+3.16%
State Bank of IndiaSBIN.NS · Mumbai, India	9.29T	1,006.40	+2.80%
Tata Consultancy Services LimitedTCS.BO · Mumbai, India	9.02T	2,493.00	+2.38%
Larsen & Toubro LimitedLT.BO · Mumbai, India	5.56T	4,042.10	+2.69%
Life Insurance Corporation of IndiaLICI.NS · Mumbai, India	5.16T	408.00	0.00%
Kotak Mahindra Bank LimitedKOTAKBANK.NS · Mumbai, India	4.65T	467.00	+1.65%

Company	Mkt cap	Price	Today
Wockhardt LimitedWOCKPHARMA.BO · chemicals & materials · life sciences · healthcare	323.45B	1,990.30	+4.76%
Grand Pharmaceutical Group Limited0512.HK · chemicals & materials · life sciences · healthcare	15.57B	4.445	+3.73%
Unichem Laboratories LimitedUNICHEMLAB.NS · chemicals & materials · life sciences · healthcare	34.73B	493.30	−2.40%
Zydus Lifesciences LimitedZYDUSLIFE.BO · chemicals & materials · life sciences · healthcare	1.19T	1,196.40	+0.54%
Joincare Pharmaceutical Group Industry Co.,Ltd.600380.SS · chemicals & materials · life sciences · healthcare	19.19B	10.49	+1.65%
Cipher Pharmaceuticals Inc.CPH.TO · chemicals & materials · life sciences · healthcare	331.16M	13.03	−0.31%
Lotus Pharmaceutical Co., Ltd.1795.TW · chemicals & materials · life sciences · healthcare	44.76B	168.00	+5.66%
IOL Chemicals and Pharmaceuticals LimitedIOLCP.NS · chemicals & materials · life sciences	55.50B	189.08	+2.89%

Company	Mkt cap	Price	Today
SUN PHARMACEUTICAL INDUSTRIESSUNPHARMA.BO	4.38T	1,825.35	+2.78%
CIPLA LTD.CIPLA.BO	1.13T	1,401.75	+0.12%
DR.REDDYS LABORATORIES LTD.DRREDDY.BO	1.13T	1,360.80	−0.82%
AUROBINDO PHARMA LTD.AUROPHARMA.BO	1.04T	1,788.30	+5.13%
GLENMARK PHARMACEUTICALS LTD.GLENMARK.BO	701.47B	2,485.50	−0.65%

News18·19h ago·2 outletsNegative

Lupin Q2 net profit falls 22.19 pc to Rs 1,155.3 cr

New Delhi, Nov 4 (PTI) Homegrown pharma major Lupin on Wednesday posted a 22.19 per cent decline in consolidated net profit to Rs 1,155.30 crore in the September quarter, dragged by an exceptional item and a drop in operating income. The…

LITE

Q2 Results 04th Nov Live: BSE, Cummins, Zydus Lifesciences, Apollo, Lenskart, Nykaa, Aurobindo Pharma, NHPC, Dabur, Torrent Power, Biocon, Sundaram Finance, Premier Energies, Physicswallah Share to announce Q2 results, Bajaj Finserv, SBI, NSE, Lupin shares in focus

Follow our stock market live updates here | Stay tuned to businessline for more. GAINERS: SBI, Emcure Pharma, Awfis Space Sensex gained 214.75 pts or 0.28% to 77,132.60 at 9.16 am after opening at 76,853.11 from 76,917.85 previous close.…

Whispers in the Corridors·22h ago·2 outletsPositive

Lupin Limited names Akhil Gupta as Independent Director to its board

Pharma major, Lupin Limited has appointed Akhil Gupta as an Independent Director to its Board. Pharma major, Lupin Limited has appointed Akhil Gupta as an Independent Director to its Board. Gupta, who was associated with the Bharti…

Lupin Q2 FY27 Results Reveal A Mixed Earnings Picture, Net Profit Declines 22% To ₹1,155 Crore Even As Sales Register A Healthy 14% Growth

Mumbai: Pharmaceutical major Lupin Limited reported a 22.2 per cent year-on-year decline in consolidated profit after tax (PAT) to ₹1,155.3 crore for the quarter ended September 30, 2026 (Q2 FY27), compared with ₹1,484.8 crore in the…

InvestyWise·1d ago

Lupin Limited Board approves Q2 FY27 unaudited financial results

Lupin Limited announced that its Board of Directors has unanimously approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026. The results, along with the limited review…

LU LKQ

Martin Cid Magazine·1d ago

Lupin Part 4 Hits No. 1 in 46 Countries on Netflix but Misses the US Top 10

That gap matters because the season did not peak on arrival. It grew. Viewing rose in the second week, the list of countries where it sits at the top roughly doubled, and the three older parts climbed back into the global chart alongside…

NFLX

InvestyWise·1d ago·2 outletsNegative

Lupin reports Q2 FY27 results with ₹77,855 million in net sales

Lupin Limited announces Q2 FY27 financial results: Net Sales ₹77,855 million (14% YoY growth), EBITDA ₹19,574 million, and Net Income ₹11,553 million. Includes regional performance and key developments. Lupin reports Q2 FY27 results with…

Lupin Gets USFDA Nod for Generic Firdapse Tablets, Qualifies for 180-Day Shared Exclusivity

Sheeba Farhat Joined Medical Dialogues in 2018 to report on the latest Education news. A Graduate of the University of Delhi, she specializes in covering stories related to Medical Education updates. For inquiries or further information,…

NVO

Business Upturn·1d agoNegative

Lupin reports Q2 FY2027 sales of INR 77,855 Mn, a 14% year-on-year increase

Pharmaceutical giant Lupin Limited has announced its financial results for the second quarter ending 30 September 2026. The company's sales during the quarter reached INR 77,855 Mn, representing a 14% increase from INR 68,314 Mn in the…

LITE

Business Upturn·1d agoPositive

Lupin appoints Akhil Gupta as Independent Director for a five-year term

Lupin Limited recruits Akhil Gupta as Independent Director, bolstering its board with his extensive experience and strategic insight. Lupin appoints Akhil Gupta as Independent Director for a five-year term In a significant boardroom…

Days on the list

30 d

1 yr

Best

Trending

—

Install

Lupin Limited

Key statistics

Against its peers

Latest news